25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SomnoMed Ltd
Buy, Hold or Sell?

Let's analyze Somnomed together

I guess you are interested in SomnoMed Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of SomnoMed Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about SomnoMed Ltd

I send you an email if I find something interesting about SomnoMed Ltd.

1. Quick Overview

1.1. Quick analysis of Somnomed (30 sec.)










1.2. What can you expect buying and holding a share of Somnomed? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.21
Expected worth in 1 year
A$0.63
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$0.42
Return On Investment
144.4%

For what price can you sell your share?

Current Price per Share
A$0.29
Expected price per share
A$0.295 - A$0.37
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Somnomed (5 min.)




Live pricePrice per Share (EOD)
A$0.29
Intrinsic Value Per Share
A$-0.64 - A$-0.18
Total Value Per Share
A$-0.43 - A$0.03

2.2. Growth of Somnomed (5 min.)




Is Somnomed growing?

Current yearPrevious yearGrowGrow %
How rich?$29.8m$14.8m$15m50.2%

How much money is Somnomed making?

Current yearPrevious yearGrowGrow %
Making money-$8.1m-$5.3m-$2.8m-34.7%
Net Profit Margin-13.4%-9.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Somnomed (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#188 / 324

Most Revenue
#95 / 324

Most Profit
#248 / 324

Most Efficient
#157 / 324
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Somnomed?

Welcome investor! Somnomed's management wants to use your money to grow the business. In return you get a share of Somnomed.

First you should know what it really means to hold a share of Somnomed. And how you can make/lose money.

Speculation

The Price per Share of Somnomed is A$0.29. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Somnomed.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Somnomed, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.21. Based on the TTM, the Book Value Change Per Share is A$0.10 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.02 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Somnomed.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.04-13.0%-0.04-13.0%-0.02-8.5%-0.02-5.7%-0.02-5.8%
Usd Book Value Change Per Share0.0723.9%0.0723.9%-0.02-5.7%0.025.8%0.013.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.014.3%0.012.7%
Usd Total Gains Per Share0.0723.9%0.0723.9%-0.02-5.7%0.0310.0%0.026.1%
Usd Price Per Share0.17-0.17-0.61-0.74-1.07-
Price to Earnings Ratio-4.46--4.46--24.67--138.01-372.52-
Price-to-Total Gains Ratio2.41-2.41--36.65--71.40--37.14-
Price to Book Ratio1.21-1.21-8.81-8.11-12.56-
Price-to-Total Gains Ratio2.41-2.41--36.65--71.40--37.14-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.192328
Number of shares5199
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share0.070.02
Usd Total Gains Per Share0.070.03
Gains per Quarter (5199 shares)360.91150.93
Gains per Year (5199 shares)1,443.65603.73
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1014441434256347594
20288728785136941198
304331432276910421802
4057755766102613892406
5072187210128217363010
6086628654153920833614
701010610098179524314218
801154911542205227784822
901299312986230831255426
1001443614430256534726030

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%2.08.00.020.0%7.013.01.033.3%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%13.08.00.061.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.08.020.0%2.00.019.09.5%
Total Gains per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%13.08.00.061.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of SomnoMed Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1050.1050%-0.025+124%0.025+316%0.015+597%
Book Value Per Share--0.2080.2080%0.104+101%0.149+40%0.137+52%
Current Ratio--1.7621.7620%1.498+18%1.757+0%2.185-19%
Debt To Asset Ratio--0.3550.3550%0.641-45%0.479-26%0.383-7%
Debt To Equity Ratio--0.5500.5500%1.789-69%1.000-45%0.715-23%
Dividend Per Share----0%-0%0.019-100%0.012-100%
Eps---0.057-0.0570%-0.037-35%-0.025-56%-0.025-55%
Free Cash Flow Per Share---0.036-0.0360%-0.048+33%-0.022-39%-0.023-36%
Free Cash Flow To Equity Per Share--0.0410.0410%-0.017+141%0.013+218%0.010+324%
Gross Profit Margin--3.1383.1380%4.062-23%8.303-62%33.638-91%
Intrinsic Value_10Y_max---0.178--------
Intrinsic Value_10Y_min---0.642--------
Intrinsic Value_1Y_max---0.021--------
Intrinsic Value_1Y_min---0.045--------
Intrinsic Value_3Y_max---0.060--------
Intrinsic Value_3Y_min---0.154--------
Intrinsic Value_5Y_max---0.097--------
Intrinsic Value_5Y_min---0.280--------
Market Cap62671320.000+13%54567270.00054567270.0000%197371436.400-72%241353736.560-77%349976100.600-84%
Net Profit Margin---0.134-0.1340%-0.096-28%-0.066-51%-0.033-75%
Operating Margin---0.091-0.0910%-0.049-46%-0.045-51%-0.025-72%
Operating Ratio--1.0421.0420%1.049-1%1.035+1%1.018+2%
Pb Ratio1.392+13%1.2121.2120%8.810-86%8.111-85%12.558-90%
Pe Ratio-5.119-15%-4.457-4.4570%-24.674+454%-138.013+2996%372.520-101%
Price Per Share0.290+13%0.2530.2530%0.913-72%1.117-77%1.619-84%
Price To Free Cash Flow Ratio-8.118-15%-7.069-7.0690%-19.172+171%-59.998+749%242.882-103%
Price To Total Gains Ratio2.771+13%2.4122.4120%-36.653+1619%-71.398+3060%-37.143+1640%
Quick Ratio--1.1651.1650%1.143+2%1.419-18%1.779-35%
Return On Assets---0.175-0.1750%-0.128-27%-0.084-52%-0.043-76%
Return On Equity---0.272-0.2720%-0.357+31%-0.172-37%-0.087-68%
Total Gains Per Share--0.1050.1050%-0.025+124%0.044+139%0.027+293%
Usd Book Value--29860046.12429860046.1240%14857917.637+101%21382786.962+40%19693677.908+52%
Usd Book Value Change Per Share--0.0690.0690%-0.017+124%0.017+316%0.010+597%
Usd Book Value Per Share--0.1380.1380%0.069+101%0.099+40%0.091+52%
Usd Dividend Per Share----0%-0%0.012-100%0.008-100%
Usd Eps---0.038-0.0380%-0.025-35%-0.017-56%-0.017-55%
Usd Free Cash Flow---5119711.672-5119711.6720%-6827502.075+33%-3099460.425-39%-3251531.124-36%
Usd Free Cash Flow Per Share---0.024-0.0240%-0.032+33%-0.014-39%-0.015-36%
Usd Free Cash Flow To Equity Per Share--0.0270.0270%-0.011+141%0.009+218%0.006+324%
Usd Market Cap41563619.424+13%36189013.46436189013.4640%130896736.620-72%160065798.087-77%232104149.918-84%
Usd Price Per Share0.192+13%0.1670.1670%0.606-72%0.741-77%1.074-84%
Usd Profit---8118712.683-8118712.6830%-5304965.981-35%-3579859.293-56%-1810107.772-78%
Usd Revenue--60782988.96160782988.9610%55454239.965+10%48791661.272+25%40255240.359+51%
Usd Total Gains Per Share--0.0690.0690%-0.017+124%0.029+139%0.018+293%
 EOD+6 -2MRQTTM+0 -0YOY+22 -125Y+16 -2010Y+17 -19

3.3 Fundamental Score

Let's check the fundamental score of SomnoMed Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.119
Price to Book Ratio (EOD)Between0-11.392
Net Profit Margin (MRQ)Greater than0-0.134
Operating Margin (MRQ)Greater than0-0.091
Quick Ratio (MRQ)Greater than11.165
Current Ratio (MRQ)Greater than11.762
Debt to Asset Ratio (MRQ)Less than10.355
Debt to Equity Ratio (MRQ)Less than10.550
Return on Equity (MRQ)Greater than0.15-0.272
Return on Assets (MRQ)Greater than0.05-0.175
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of SomnoMed Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.280
Total0/1 (0.0%)

4. In-depth Analysis

4.1 About SomnoMed Ltd

SomnoMed Limited, together with its subsidiaries, engages in the production and sale of devices for the oral appliances for the treatment of sleep related disorders in Europe, North America, and the Asia Pacific region. Its flagship product SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs are cleaning tablets, developed to clean oral appliances safely and effectively. In addition, it also provides sleep test at home under the Sunrise brand name. The company was incorporated in 1987 and is headquartered in Crows Nest, Australia.

Fundamental data was last updated by Penke on 2024-10-17 00:15:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Somnomed earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Net Profit Margin of -13.4% means that $-0.13 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of SomnoMed Ltd:

  • The MRQ is -13.4%. The company is making a huge loss. -2
  • The TTM is -13.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-9.6%-3.8%
TTM-13.4%5Y-6.6%-6.8%
5Y-6.6%10Y-3.3%-3.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.4%-10.5%-2.9%
TTM-13.4%-16.0%+2.6%
YOY-9.6%-15.5%+5.9%
5Y-6.6%-17.9%+11.3%
10Y-3.3%-23.4%+20.1%
4.3.1.2. Return on Assets

Shows how efficient Somnomed is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -17.5% Return on Assets means that Somnomed generated $-0.18 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of SomnoMed Ltd:

  • The MRQ is -17.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -17.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.5%TTM-17.5%0.0%
TTM-17.5%YOY-12.8%-4.7%
TTM-17.5%5Y-8.4%-9.2%
5Y-8.4%10Y-4.3%-4.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.5%-3.1%-14.4%
TTM-17.5%-3.5%-14.0%
YOY-12.8%-3.9%-8.9%
5Y-8.4%-3.1%-5.3%
10Y-4.3%-4.0%-0.3%
4.3.1.3. Return on Equity

Shows how efficient Somnomed is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • -27.2% Return on Equity means Somnomed generated $-0.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of SomnoMed Ltd:

  • The MRQ is -27.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -27.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.2%TTM-27.2%0.0%
TTM-27.2%YOY-35.7%+8.5%
TTM-27.2%5Y-17.2%-10.0%
5Y-17.2%10Y-8.7%-8.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.2%-2.7%-24.5%
TTM-27.2%-3.9%-23.3%
YOY-35.7%-4.2%-31.5%
5Y-17.2%-4.6%-12.6%
10Y-8.7%-5.5%-3.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of SomnoMed Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Somnomed is operating .

  • Measures how much profit Somnomed makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • An Operating Margin of -9.1% means the company generated $-0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of SomnoMed Ltd:

  • The MRQ is -9.1%. The company is operating very inefficient. -2
  • The TTM is -9.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-9.1%TTM-9.1%0.0%
TTM-9.1%YOY-4.9%-4.2%
TTM-9.1%5Y-4.5%-4.6%
5Y-4.5%10Y-2.5%-1.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.1%-14.8%+5.7%
TTM-9.1%-18.2%+9.1%
YOY-4.9%-13.3%+8.4%
5Y-4.5%-17.3%+12.8%
10Y-2.5%-19.6%+17.1%
4.3.2.2. Operating Ratio

Measures how efficient Somnomed is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.04 means that the operating costs are $1.04 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.042. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.042. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.042TTM1.0420.000
TTM1.042YOY1.049-0.007
TTM1.0425Y1.035+0.007
5Y1.03510Y1.018+0.017
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0421.320-0.278
TTM1.0421.347-0.305
YOY1.0491.340-0.291
5Y1.0351.365-0.330
10Y1.0181.323-0.305
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of SomnoMed Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Somnomed is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.76 means the company has $1.76 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.762. The company is able to pay all its short-term debts. +1
  • The TTM is 1.762. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.762TTM1.7620.000
TTM1.762YOY1.498+0.264
TTM1.7625Y1.757+0.005
5Y1.75710Y2.185-0.428
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7622.595-0.833
TTM1.7622.661-0.899
YOY1.4983.012-1.514
5Y1.7573.416-1.659
10Y2.1853.514-1.329
4.4.3.2. Quick Ratio

Measures if Somnomed is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Quick Ratio of 1.16 means the company can pay off $1.16 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of SomnoMed Ltd:

  • The MRQ is 1.165. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.165. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.165TTM1.1650.000
TTM1.165YOY1.143+0.022
TTM1.1655Y1.419-0.255
5Y1.41910Y1.779-0.359
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1651.572-0.407
TTM1.1651.682-0.517
YOY1.1431.910-0.767
5Y1.4192.330-0.911
10Y1.7792.558-0.779
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of SomnoMed Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Somnomed assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Somnomed to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.35 means that Somnomed assets are financed with 35.5% credit (debt) and the remaining percentage (100% - 35.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of SomnoMed Ltd:

  • The MRQ is 0.355. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.355. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.355TTM0.3550.000
TTM0.355YOY0.641-0.286
TTM0.3555Y0.479-0.124
5Y0.47910Y0.383+0.096
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3550.400-0.045
TTM0.3550.400-0.045
YOY0.6410.354+0.287
5Y0.4790.437+0.042
10Y0.3830.457-0.074
4.5.4.2. Debt to Equity Ratio

Measures if Somnomed is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Somnomed to the Medical Devices industry mean.
  • A Debt to Equity ratio of 55.0% means that company has $0.55 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of SomnoMed Ltd:

  • The MRQ is 0.550. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.550. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.550TTM0.5500.000
TTM0.550YOY1.789-1.239
TTM0.5505Y1.000-0.450
5Y1.00010Y0.715+0.285
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5500.559-0.009
TTM0.5500.555-0.005
YOY1.7890.525+1.264
5Y1.0000.633+0.367
10Y0.7150.693+0.022
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Somnomed generates.

  • Above 15 is considered overpriced but always compare Somnomed to the Medical Devices industry mean.
  • A PE ratio of -4.46 means the investor is paying $-4.46 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of SomnoMed Ltd:

  • The EOD is -5.119. Based on the earnings, the company is expensive. -2
  • The MRQ is -4.457. Based on the earnings, the company is expensive. -2
  • The TTM is -4.457. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.119MRQ-4.457-0.662
MRQ-4.457TTM-4.4570.000
TTM-4.457YOY-24.674+20.217
TTM-4.4575Y-138.013+133.556
5Y-138.01310Y372.520-510.534
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.119-1.098-4.021
MRQ-4.457-1.292-3.165
TTM-4.457-2.198-2.259
YOY-24.674-2.330-22.344
5Y-138.013-2.068-135.945
10Y372.520-2.037+374.557
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of SomnoMed Ltd:

  • The EOD is -8.118. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.069. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.069. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.118MRQ-7.069-1.050
MRQ-7.069TTM-7.0690.000
TTM-7.069YOY-19.172+12.103
TTM-7.0695Y-59.998+52.929
5Y-59.99810Y242.882-302.880
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-8.118-1.540-6.578
MRQ-7.069-1.745-5.324
TTM-7.069-2.233-4.836
YOY-19.172-5.534-13.638
5Y-59.998-3.774-56.224
10Y242.882-4.739+247.621
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Somnomed is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.21 means the investor is paying $1.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of SomnoMed Ltd:

  • The EOD is 1.392. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.212. Based on the equity, the company is underpriced. +1
  • The TTM is 1.212. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.392MRQ1.212+0.180
MRQ1.212TTM1.2120.000
TTM1.212YOY8.810-7.598
TTM1.2125Y8.111-6.899
5Y8.11110Y12.558-4.447
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.3922.045-0.653
MRQ1.2122.141-0.929
TTM1.2122.356-1.144
YOY8.8102.926+5.884
5Y8.1114.079+4.032
10Y12.5584.603+7.955
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of SomnoMed Ltd.

4.8.2. Funds holding SomnoMed Ltd

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2021-01-31Fidelity International Small Cap Fund4.71-3898596--
2021-01-31DFA Asia Pacific Small Company Series0.029999999-25160--
Total 4.7399999990392375600.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Accumulated Other Comprehensive Income  8,558-7977,760527,8132,61410,427-10,884-458
Long-term Assets Other  -6,469209-6,260222-6,038-453-6,49118,34411,853



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. All numbers in thousands.

Summary
Total Assets69,805
Total Liabilities24,780
Total Stockholder Equity45,024
 As reported
Total Liabilities 24,780
Total Stockholder Equity+ 45,024
Total Assets = 69,805

Assets

Total Assets69,805
Total Current Assets35,139
Long-term Assets34,666
Total Current Assets
Cash And Cash Equivalents 16,179
Net Receivables 7,051
Inventory 6,285
Other Current Assets 1,192
Total Current Assets  (as reported)35,139
Total Current Assets  (calculated)30,707
+/- 4,432
Long-term Assets
Property Plant Equipment 11,147
Goodwill 6,343
Intangible Assets 2,122
Long-term Assets Other 11,853
Long-term Assets  (as reported)34,666
Long-term Assets  (calculated)31,465
+/- 3,201

Liabilities & Shareholders' Equity

Total Current Liabilities19,944
Long-term Liabilities4,837
Total Stockholder Equity45,024
Total Current Liabilities
Short-term Debt 307
Accounts payable 13,111
Other Current Liabilities 6,343
Total Current Liabilities  (as reported)19,944
Total Current Liabilities  (calculated)19,761
+/- 182
Long-term Liabilities
Long-term Liabilities  (as reported)4,837
Long-term Liabilities  (calculated)0
+/- 4,837
Total Stockholder Equity
Common Stock119,962
Retained Earnings -74,480
Accumulated Other Comprehensive Income -458
Other Stockholders Equity 0
Total Stockholder Equity (as reported)45,024
Total Stockholder Equity (calculated)45,024
+/-0
Other
Cash and Short Term Investments 16,179
Common Stock Shares Outstanding 120,717
Current Deferred Revenue182
Liabilities and Stockholders Equity 69,805
Net Debt -15,163
Net Working Capital 15,195
Short Long Term Debt Total 1,016



5.3. Balance Sheets Structured

All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-30
> Total Assets 
118
625
7,918
4,069
4,699
7,004
6,038
7,834
8,732
12,312
18,302
19,143
27,751
40,427
41,212
45,698
34,751
61,693
56,166
58,094
62,491
69,805
69,80562,49158,09456,16661,69334,75145,69841,21240,42727,75119,14318,30212,3128,7327,8346,0387,0044,6994,0697,918625118
   > Total Current Assets 
0
78
6,768
2,645
3,594
6,212
5,519
6,074
6,328
7,779
9,459
9,405
16,778
27,170
26,355
28,968
20,158
40,235
34,127
30,315
27,496
35,139
35,13927,49630,31534,12740,23520,15828,96826,35527,17016,7789,4059,4597,7796,3286,0745,5196,2123,5942,6456,768780
       Cash And Cash Equivalents 
107
51
6,636
2,310
3,205
5,433
4,009
4,294
3,949
3,538
4,221
2,945
8,306
17,632
14,210
13,383
7,697
30,174
21,110
15,644
11,956
16,179
16,17911,95615,64421,11030,1747,69713,38314,21017,6328,3062,9454,2213,5383,9494,2944,0095,4333,2052,3106,63651107
       Short-term Investments 
11
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000011
       Net Receivables 
0
27
132
317
381
746
1,426
1,584
2,202
3,741
3,917
4,346
5,299
6,059
6,619
10,404
7,117
6,126
8,225
9,202
9,029
7,051
7,0519,0299,2028,2256,1267,11710,4046,6196,0595,2994,3463,9173,7412,2021,5841,426746381317132270
       Other Current Assets 
0
0
0
0
0
0
182
54
0
21
466
1,149
1,880
1,788
3,578
3,178
3,441
1,692
2,462
2,380
2,410
1,192
1,1922,4102,3802,4621,6923,4413,1783,5781,7881,8801,14946621054182000000
   > Long-term Assets 
0
546
1,150
1,424
1,105
793
519
1,759
2,404
4,532
6,310
7,031
7,738
10,079
11,072
13,433
10,912
21,458
22,040
27,778
34,996
34,666
34,66634,99627,77822,04021,45810,91213,43311,07210,0797,7387,0316,3104,5322,4041,7595197931,1051,4241,1505460
       Property Plant Equipment 
0
27
658
985
676
457
235
642
1,140
1,069
1,155
1,251
2,105
3,573
4,491
5,690
3,248
10,239
10,342
9,116
12,730
11,147
11,14712,7309,11610,34210,2393,2485,6904,4913,5732,1051,2511,1551,0691,140642235457676985658270
       Goodwill 
0
0
0
0
0
0
0
0
0
1,321
4,856
5,690
5,477
6,238
6,171
6,375
6,407
6,469
6,260
6,038
6,491
6,343
6,3436,4916,0386,2606,4696,4076,3756,1716,2385,4775,6904,8561,321000000000
       Intangible Assets 
0
520
491
440
388
336
284
232
328
1,513
76
90
156
268
410
1,367
1,257
7,929
8,581
15,448
18,974
2,122
2,12218,97415,4488,5817,9291,2571,36741026815690761,5133282322843363884404915200
       Other Assets 
0
0
0
0
0
0
0
857
999
1,855
2,533
2,707
3,235
3,178
3,785
3,297
3,681
3,589
4,370
9,835
3,252
0
03,2529,8354,3703,5893,6813,2973,7853,1783,2352,7072,5331,8559998570000000
> Total Liabilities 
3
785
716
835
786
996
1,705
2,183
2,515
3,392
6,729
6,573
6,243
7,739
10,257
12,929
16,931
27,858
24,008
30,305
40,088
24,780
24,78040,08830,30524,00827,85816,93112,92910,2577,7396,2436,5736,7293,3922,5152,1831,7059967868357167853
   > Total Current Liabilities 
3
785
461
741
786
996
1,705
2,181
2,509
3,380
4,782
4,736
5,471
7,577
9,949
11,540
16,046
18,780
16,197
23,775
18,360
19,944
19,94418,36023,77516,19718,78016,04611,5409,9497,5775,4714,7364,7823,3802,5092,1811,7059967867414617853
       Short-term Debt 
0
0
157
157
92
0
196
5
545
54
0
0
0
20
69
398
3,236
7,284
1,956
6,657
2,569
307
3072,5696,6571,9567,2843,236398692000054545519609215715700
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
123
1,435
3,008
4,953
0
4,877
313
0
03134,87704,9533,0081,43512300000000000000
       Accounts payable 
0
778
251
446
614
835
1,456
1,868
2,202
2,449
3,077
3,046
3,708
6,065
7,545
8,084
7,828
8,277
10,334
12,593
11,996
13,111
13,11111,99612,59310,3348,2777,8288,0847,5456,0653,7083,0463,0772,4492,2021,8681,4568356144462517780
       Other Current Liabilities 
3
7
54
138
80
161
249
133
307
338
1,704
1,690
1,763
1,512
1,997
2,761
4,705
2,928
3,647
4,263
3,561
6,343
6,3433,5614,2633,6472,9284,7052,7611,9971,5121,7631,6901,704338307133249161801385473
   > Long-term Liabilities 
0
0
255
94
0
0
0
2
5
12
139
1,837
772
161
308
1,389
885
9,077
7,811
6,530
21,728
4,837
4,83721,7286,5307,8119,0778851,3893081617721,83713912520009425500
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
1,037
359
8,246
6,952
5,353
20,941
0
020,9415,3536,9528,2463591,0375300000000000000
       Other Liabilities 
0
0
0
0
0
0
0
2
5
12
139
1,837
772
161
255
352
526
831
859
1,177
787
0
07871,1778598315263522551617721,83713912520000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
312
248
116
52
37
110
299
1,254
6,620
9,668
0
09,6686,6201,254299110375211624831200000000000
> Total Stockholder Equity
115
-160
7,201
3,234
3,913
6,009
4,333
5,651
6,217
8,437
11,402
12,338
21,340
33,128
32,214
36,119
17,820
33,835
32,158
27,788
22,403
45,024
45,02422,40327,78832,15833,83517,82036,11932,21433,12821,34012,33811,4028,4376,2175,6514,3336,0093,9133,2347,201-160115
   Retained Earnings -74,480-62,295-54,296-49,859-48,666-47,491-27,731-19,140-15,767-15,904-16,501-17,097-18,126-18,651-19,390-20,177-18,358-15,627-12,352-7,709-4,4420
   Accumulated Other Comprehensive Income 
0
-1
-35
676
926
1,096
1,239
1,334
827
1,159
2,398
2,403
3,566
4,372
4,416
6,135
7,685
8,558
7,760
7,813
10,427
-458
-45810,4277,8137,7608,5587,6856,1354,4164,3723,5662,4032,3981,1598271,3341,2391,096926676-35-10
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000



5.4. Balance Sheets

All numbers in thousands.




5.5. Cash Flows

All numbers in thousands.